Nihar R. Pandey, Ph.D.
President & CEO
Dr. Nihar Pandey is the founding President and CEO of Anthem Pharmaceuticals Inc. He founded Medipure Pharmaceuticals Inc. in 2014 and served as its Chief Scientific Officer and CEO. He has also held the role of Chief Scientific Officer at CliniCan Health Research and currently serves in the same capacity at Paws Pharma in Canada.
Dr. Pandey holds a Ph.D. in Clinical Biochemistry and has more than 25 years of experience in life sciences, pharmaceutical R&D, and business development. He is recognized as a key opinion leader (KOL) in drug discovery, development, and therapeutic approval across multiple areas, including metabolic diseases (diabetes, obesity, cardiovascular), neuroscience, dermatology, and endocannabinoid research, with a Concept-to-Market approach.
He completed postdoctoral training at the Department of Medicine, University of Montreal, the Clinical Research Institute of Montreal, and McGill University, Canada. He was appointed as a Research Scientist at the University of Ottawa Heart Institute and The Ottawa Hospital (OHRI–Neuroscience) and later became Group Leader for Drug Discovery and Development at Liponex Inc., Ottawa.
Nihar also received clinical research training and worked at Health Canada in regulatory toxicology. He has published more than 35 peer-reviewed research papers, holds 5 active patents, and has contributed to 2 book chapters. In addition, he serves as a scientific reviewer for leading medical and life science journals, including Circulation, Circulation Research, The Lancet, Hypertension, Journal of Cell Biology, Lancet Diabetes, Molecular Neuroscience, and Metabolism.
He brings extensive expertise in business development and R&D related to drugs and medical devices, including controlled drug substances.